Related Experiment Video
Updated: Jul 8, 2026

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins
Published on: October 4, 2017
Effects of mutations and glycosylations on STS activity: a site-directed mutagenesis study
Chloe Stengel1, Simon P Newman, Joanna M Day
1Endocrinology and Metabolic Medicine and Sterix Ltd., Faculty of Medicine, Imperial College London, St. Mary's Hospital, London, W2 1NY, UK. c.stengel@imperial.ac.uk
Abstract:
Steroid sulphatase (STS) catalyses the formation of active steroids from inactive steroid sulphates. High levels of intra-tumoural STS mRNA are associated with a poor prognosis in post-menopausal patients with oestrogen receptor positive breast cancer. In this study, analysis of the mutated STS protein showed that N- and C-terminal truncated STS constructs are inactive. Histidine 136, located inside the active site, is crucial for STS activity whereas proline 212, which allows the protein turn into the membrane, is not. Mutations in glycosylation sites asparagine 47 and 259 decreased STS activity while asparagine 333 and 459 mutations did not affect it. However, immunoblot studies revealed that all four N-linked sites are glycosylated to some extent. In addition, a polyclonal antibody raised in rabbits against human STS was developed and characterised. These data increase our knowledge of the STS enzyme structure and may help design new STS inhibitors.
Insights
Steroid sulphatase (STS) is crucial for active steroid formation. Understanding its structure and mutations, like those affecting Histidine 136, aids in developing targeted STS inhibitors for breast cancer treatment.
Area of Science:
- Biochemistry
- Enzymology
- Molecular Biology
Background:
- Steroid sulphatase (STS) converts inactive steroid sulphates to active steroids.
- Elevated intra-tumoural STS mRNA correlates with poor prognosis in oestrogen receptor-positive breast cancer patients.
Purpose of the Study:
- To investigate the structure-function relationship of the Steroid Sulphatase (STS) enzyme.
- To identify key amino acid residues and glycosylation sites critical for STS activity.
- To develop and characterize an antibody against human STS.
Main Methods:
- Site-directed mutagenesis of STS protein constructs.
- Enzymatic activity assays to measure STS function.
- Immunoblot analysis to assess glycosylation.
- Development and characterization of a polyclonal anti-STS antibody.
Main Results:
- N- and C-terminal truncated STS proteins were inactive.
- Histidine 136 is essential for STS catalytic activity, while Proline 212 is not.
- Mutations at glycosylation sites N47 and N259 reduced STS activity, unlike N333 and N459.
- All four N-linked glycosylation sites showed some degree of glycosylation.
Conclusions:
- Specific amino acid residues and glycosylation sites significantly influence STS enzyme activity.
- The developed anti-STS antibody can be a valuable tool for further research.
- These findings provide insights for designing novel STS inhibitors for therapeutic applications.
More Related Videos
07:04Site-Directed Mutagenesis for In Vitro and In Vivo Experiments Exemplified with RNA Interactions in Escherichia Coli
Published on: February 5, 2019
11:49A Novel Saturation Mutagenesis Approach: Single Step Characterization of Regulatory Protein Binding Sites in RNA Using Phosphorothioates
Published on: August 21, 2018
Related Concept Videos
Ligand Binding and Linkage
Mutations